RESULTS	FEV1 was improved at the end of treatment ( EOT ) with meropenem/tobramycin ( mean [ + / - SD ] increase , 38.8 + / - 52.3 % ) and with ceftazidime/tobramycin ( mean increase , 29.4 + / - 35.1 % ; p < 0.0001 vs baseline values ) .\